AI
ZURA icon

Atom Investors’s Zura Bio ZURA Stock Holding History

Atom Investors’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-77,416
Closed -$271K – 629
2024
Q2 		$271K Sell
77,416
-17,566
-18% -$71.6K 0.03% 387
2024
Q1 		$244K Buy
94,982
+48,714
+105% +$173K 0.03% 455
2023
Q4 		$216K Buy
+46,268
New +$231K 0.04% 395

Other funds holding ZURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Atom Investors's ZURA Position: Q3 2024 in Review

Atom Investors sold out of Zura Bio (ZURA) in Q3 2024, closing a stake of 77,416 shares — an estimated $271K sold.

Atom Investors first reported a position in ZURA in Q4 2023 and held it in 3 quarters. The position peaked at $271K in Q2 2024. 78 funds tracked by Wall St. Rank hold ZURA as of Q3 2024.

  • Atom Investors reported no remaining Zura Bio position as of Q3 2024 after selling out during the quarter.
  • Atom Investors sold 77,416 Zura Bio shares in Q3 2024, an estimated $271K.
  • Atom Investors first reported a position in Zura Bio in Q4 2023 and held it in 3 quarters.
  • Atom Investors's Zura Bio position peaked at $271K in Q2 2024.
  • 78 funds tracked by Wall St. Rank held Zura Bio as of Q3 2024.

Based on Atom Investors's 13F filing for Q3 2024, filed 14 Nov 2024.